Cargando…
Development of a radiosensitivity gene signature for patients with soft tissue sarcoma
Adjuvant radiotherapy is an important clinical treatment option for the majority of sarcomas. The motivation of current study is to identify a gene signature and to predict radiosensitive patients who are most likely to benefit from radiotherapy. Using the public available data of soft tissue sarcom...
Autores principales: | Tang, Zaixiang, Zeng, Qinghua, Li, Yan, Zhang, Xinyan, Ma, Jinlu, Suto, Mark J., Xu, Bo, Yi, Nengjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432346/ https://www.ncbi.nlm.nih.gov/pubmed/28404969 http://dx.doi.org/10.18632/oncotarget.16194 |
Ejemplares similares
-
Predicting radiotherapy response for patients with soft tissue sarcoma by developing a molecular signature
por: Tang, Zaixiang, et al.
Publicado: (2017) -
Development and validation of an immune-related gene signature for predicting the radiosensitivity of lower-grade gliomas
por: Yan, Derui, et al.
Publicado: (2022) -
Development and Validation of a Radiosensitivity Prediction Model for Lower Grade Glioma Based on Spike-and-Slab Lasso
por: Du, Zixuan, et al.
Publicado: (2021) -
Developing ZNF Gene Signatures Predicting Radiosensitivity of Patients with Breast Cancer
por: Yan, Derui, et al.
Publicado: (2021) -
More evidence for prediction model of radiosensitivity
por: Du, Zixuan, et al.
Publicado: (2021)